Key facts
- This page summarizes John K. Scott Jr.'s Form 4 filing for NAVIDEA BIOPHARMACEUTICALS, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jun 2023, 10:46.
John K. Scott Jr. - 29 Jun 2023 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 29 Jun 2023
- Net transaction value
- +$1,073,600
- SEC form
- 4
- Accepted by SEC
- 30 Jun 2023, 10:46:07 UTC
- Prior SEC filing
- 15 Jun 2023
- Next SEC filing
- 05 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joseph W. Meyer for John K. Scott, Jr. by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John K. Scott Jr. filed Form 4 for NAVIDEA BIOPHARMACEUTICALS, INC. on 30 Jun 2023.
Change
- Previous filing in this sequence was filed on 15 Jun 2023.
- Current net transaction value: +$1,073,600.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NAVB
transaction
Common Stock
Award
- Transaction value
- $1,073,600
- Shares
- +12,200,000
- Change %
- +62%
- Price
- $0.0880
- Shares after
- 31,755,832
- Date
- 29 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
NAVB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,139
- Date
- 29 Jun 2023
- Ownership
- By spouse and children
- Footnotes
- F2
NAVB
holding
Series G Redeemable Preferred Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,270
- Date
- 29 Jun 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Navidea entered into a Letter Agreement with the Reporting Person, pursuant to which the Company agreed to repay $1,073,600 principal amount of an outstanding Term Note by issuing to the Reporting Person 12,200,000 shares of Common Stock, based on the closing stock price of $0.088 per share on June 28, 2023.
Footnote F2
Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.